Study guide
7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
ABWM Certified Wound Specialist CWS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy
2 Chapter 2: Comprehensive Patient & Wound Assessment
2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment
3 Chapter 3: Vascular Assessment & Diagnostic Testing
Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment
4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches
Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds
5 Chapter 5: Physiology of Wound Healing & Tissue Repair
5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)
6 Chapter 6: Biofilm Biology & Wound Bed Preparation
6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management
7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage
7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)
Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema
9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds
Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management
10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies
Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types
11 Chapter 11: Debridement & Topically Applied Therapies
Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics
12 Chapter 12: Compression Therapy & Advanced Off-Loading
Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection
13 Chapter 13: Advanced & Adjunctive Wound Therapies
Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management
14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care
14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement
7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
Key Takeaways Explain This Topic AI
MASD encompasses four distinct clinical categories: Incontinence-Associated Dermatitis (IAD), Intertriginous Dermatitis (ITD/Intertrigo), Periwound MASD, and Peristomal MASD.
Incontinence-Associated Dermatitis (IAD) is a top-down chemical injury caused by alkaline urine pH activating fecal lipases and proteases, breaking down stratum corneum lipid bilayers.
IAD presents as diffuse, irregular, blotchy erythema in skin folds/perineum without necrotic tissue, slough, or eschar; Stage 1/2 pressure injuries occur over bony prominences with circumscribed borders.
Skin barrier protectants include petrolatum (occlusive base), dimethicone (breathable silicone barrier), zinc oxide (thick physical barrier for enzymatic stool), and cyanoacrylates (polymeric film for denuded skin).
Secondary Candida albicans superinfection in IAD/ITD presents with fiery red erythema and characteristic satellite macules/pustules, requiring topical antifungal powder/cream.
Last updated: July 2026
7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
Moisture-Associated Skin Damage (MASD) encompasses a spectrum of cutaneous inflammatory conditions caused by prolonged exposure of the skin to various moisture sources, including urine, feces, perspiration, wound exudate, and digestive secretions. A core competency evaluated on the Certified Wound Specialist (CWS) examination is the precise clinical differentiation between MASD—specifically Incontinence-Associated Dermatitis (IAD)—and pressure injuries. Misdiagnosing IAD as a pressure injury leads to inappropriate treatment strategies, misallocation of clinical resources, and inaccurate quality reporting.
Pathophysiology & Etiology of MASD
Healthy skin functions as a protective barrier maintained by the stratum corneum, an acidic skin mantle (pH 4.5 – 5.5), and tightly organized intercellular lipid bilayers. Exposure to excessive moisture breaks down this protective barrier through several mechanisms:
Stratum Corneum Overhydration (Maceration): Hyperhydration disrupts intracellular keratin filament bundles and expands intercellular lipid spaces, causing swelling, softening, and loss of skin structural integrity. Macerated skin exhibits a characteristic pale, waterlogged, wrinkled appearance.
Loss of Barrier Function: Maceration dramatically increases skin permeability to chemical irritants and pathogens, while increasing susceptibility to friction-induced epidermal stripping (denudation).
Alkaline pH Shift & Enzymatic Activation: In the setting of incontinence, urea-splitting bacteria convert urinary urea into ammonia, elevating skin pH into an alkaline range (> 7.0). Alkaline pH activates digestive enzymes present in feces—specifically lipases and proteases . Active proteases degrade stratum corneum proteins (corneodesmosomes), while lipases break down intercellular lipids, resulting in rapid chemical digestion of the epidermis.
The Four Clinical Categories of MASD
MASD is classified into four distinct clinical entities based on moisture source and anatomical location:
1. Incontinence-Associated Dermatitis (IAD)
Definition: Inflammation and superficial erosion of the skin secondary to liquid contact with urine or stool.
Anatomical Distribution: Perineum, perianal region, gluteal cleft, upper inner thighs, and lower abdomen.
Risk Factors: Liquid stool (diarrhea), dual incontinence (fecal + urinary), frequent bowel movements, impaired mobility, and cognitive impairment. Fecal incontinence presents a significantly higher risk than urinary incontinence alone due to active digestive enzymes.
2. Intertriginous Dermatitis (ITD / Intertrigo)
Definition: Inflammatory skin condition caused by friction between opposing skin folds combined with trapped perspiration and inadequate air circulation.
Anatomical Sites: Inframammary folds, abdominal pannicus folds, axillae, groin folds, and gluteal cleft.
Features: Linear mirror-image erythema along the base of the skin fold, often accompanied by maceration, erosion, and a characteristic musty odor. Secondary fungal overgrowth ( Candida albicans ) is extremely common.
3. Periwound MASD
Definition: Maceration and breakdown of skin immediately surrounding a chronic wound (within 4 cm of wound margin).
Etiology: Sustained contact with highly exudative wounds. Chronic wound exudate contains elevated levels of inflammatory cytokines, matrix metalloproteinases (MMPs), and bacteria, which degrade native periwound skin proteins.
4. Peristomal MASD
Definition: Inflammation and erosion of skin surrounding a stoma (e.g., ileostomy, colostomy, urostomy).
Etiology: Corrosive stomal effluent (particularly liquid fecal effluent rich in pancreatic enzymes from an ileostomy) leaking beneath an ill-fitting pouching system barrier wafer.
Differential Diagnosis: IAD vs. Stage 1 / Stage 2 Pressure Injury
Accurate clinical distinction between IAD and pressure injuries is a frequent, high-yield CWS exam topic.
Diagnostic Parameter Incontinence-Associated Dermatitis (IAD) Pressure Injury (Stage 1 or Stage 2)
Primary Etiology Top-down chemical breakdown & moisture exposure (urine/stool) Bottom-up mechanical force (pressure, shear, tissue deformation)
Anatomical Location Diffuse; perineum, buttocks, inner thighs, skin folds Localized over bony prominences (sacrum, ischium, trochanter, heels)
Lesion Boundaries Diffuse, irregular, blotchy, scattered, poorly demarcated Circumscribed, distinct, well-demarcated edges
Color & Erythema Bright red, pink, non-uniform; blanches initially Stage 1: Non-blanchable erythema; DTPI: deep red/maroon/purple
Depth of Damage Partial-thickness (epidermal loss/erosion; dermis intact) Stage 1 (intact), Stage 2 (dermal exposure), Stage 3/4 (full-thickness)
Necrosis / Slough NEVER contains necrotic tissue, slough, or eschar Slough or eschar frequently present in Stage 3, Stage 4, or Unstageable
Secondary Lesions Vesicles, bullae, papules, satellite lesions ( Candida ) Undermining, tunneling, epibole, exposed deep structures
Patient Symptoms Burning, stinging, smarting, intense superficial pain Deep pressure ache, localized tenderness, throbbing pain
Prevention & Management Protocols for MASD & IAD
Effective management requires a two-pronged strategy: eliminating or mitigating the moisture source, and restoring/protecting the epidermal skin barrier.
1. Gentle Skin Cleansing Protocols
Avoid Alkaline Bar Soap: Standard bar soaps have an alkaline pH (9.0 – 10.0) that strips natural skin lipids, neutralizes the acid mantle, and worsens enzymatic skin breakdown.
pH-Balanced No-Rinse Cleansers: Cleanse skin immediately after each incontinent episode using a dedicated, pH-balanced (pH 5.5), non-rinse skin cleanser containing mild surfactants.
Technique: Softly wipe or pat skin dry; avoid aggressive rubbing with rough terrycloth washcloths, which creates mechanical friction and denudes fragile skin.
2. Skin Barrier Protectant Formulations
Skin protectants form a hydrophobic barrier over the epidermis, preventing urine, feces, and moisture from contacting skin proteins.
Protectant Active Ingredient Mechanism of Action & Properties Indications & Clinical Considerations
Petrolatum Hydrophobic petroleum jelly base; creates an occlusive moisture barrier Prevention of mild IAD; inexpensive; can clog incontinence pad pores if applied heavily
Dimethicone Silicone-based liquid polymer; forms a breathable, water-repellent film Ideal for daily prevention; allows transepidermal water vapor transmission; non-greasy
Zinc Oxide Inorganic compound; thick, viscous physical barrier ointment Excellent protection against aggressive liquid stool and enzymatic diarrhea; highly durable
Cyanoacrylates Alcohol-free liquid skin protectant forming a durable polymeric film Severe IAD with denuded, weeping skin; forms transparent barrier; lasts up to 72 hours
Clinical Removal Rule for Zinc Oxide: Zinc oxide ointment is intentionally difficult to wash off. Clinicians must not scrub zinc oxide off completely during routine incontinence care, as forceful scrubbing causes friction damage. Only the top soiled layer should be gently wiped away, leaving the clean base layer intact before applying a fresh layer.
3. Management of Fungal Superinfections
Secondary fungal infection—predominantly by Candida albicans —frequently complicates IAD and Intertrigo due to warm, moist, alkaline conditions.
Clinical Presentation: Bright red maculopapular rash, fiery red erythema, scaling edges, and pathognomonic satellite macules or pustules spreading outward from the main body of inflammation.
Therapeutic Protocol: Apply a topical antifungal agent (e.g., nystatin or miconazole powder or cream) twice daily. Antifungal powder is preferred in moist skin folds (ITD) to absorb excess moisture. Once the antifungal agent is applied, a breathable skin barrier protectant (e.g., dimethicone) must be layered over it to preserve barrier integrity.